• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

便潜血检测对于左、右侧结直肠肿瘤的检测敏感性更高吗?系统文献回顾。

Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review.

机构信息

Division of Preventive Oncology, National Center for Tumor Diseases/German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.

出版信息

Expert Rev Mol Diagn. 2011 Jul;11(6):605-16. doi: 10.1586/erm.11.41.

DOI:10.1586/erm.11.41
PMID:21745014
Abstract

Owing to its slow development from removable precursor lesions and early cancer stages with good prognosis, screening for colorectal cancer holds potential to reduce both the incidence and mortality of the disease. While sigmoidoscopy only detects left-sided neoplasia, there is accumulating evidence that colonoscopy is also more effective in protecting from neoplasia in the left versus the right colon and rectum. In this context, it is an important question whether the sensitivity of the most common noninvasive screening tool for colorectal cancer, fecal occult blood testing (FOBT), also differs for left- versus right-sided neoplasia. Therefore, we systematically searched the literature for prospective screening studies conducted in average-risk adults that performed FOBT (immunochemical and/or guaiac-based) and colonoscopy among all participants, and reported site-specific sensitivities of FOBT for advanced colorectal neoplasia. Most of the seven included studies showed a higher sensitivity of FOBT for advanced neoplasia in the left versus right colon, but this finding needs to be confirmed since the available literature is scarce and not entirely consistent.

摘要

由于结直肠癌从可切除的前体病变和预后良好的早期癌症阶段发展缓慢,因此筛查结直肠癌具有降低疾病发病率和死亡率的潜力。虽然乙状结肠镜检查仅能检测左侧肿瘤,但越来越多的证据表明,结肠镜检查在预防左侧与右侧结肠和直肠肿瘤方面也更有效。在这种情况下,一个重要的问题是,最常见的非侵入性结直肠癌筛查工具粪便潜血检测(FOBT)对左侧与右侧肿瘤的敏感性是否也不同。因此,我们系统地检索了文献,以寻找在普通风险成年人中进行的前瞻性筛查研究,这些研究对所有参与者进行了 FOBT(免疫化学和/或愈创木脂基)和结肠镜检查,并报告了 FOBT 对结直肠高级别肿瘤的特定部位敏感性。纳入的 7 项研究中的大多数都表明 FOBT 对左半结肠高级别肿瘤的敏感性更高,但这一发现需要得到证实,因为现有文献有限且并不完全一致。

相似文献

1
Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review.便潜血检测对于左、右侧结直肠肿瘤的检测敏感性更高吗?系统文献回顾。
Expert Rev Mol Diagn. 2011 Jul;11(6):605-16. doi: 10.1586/erm.11.41.
2
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.基于愈创木脂的粪便潜血试验与粪便免疫化学试验用于一般风险人群结直肠癌筛查。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.
3
Cascade colorectal cancer screening guidelines: a global conceptual model.级联结直肠癌筛查指南:一个全球概念模型。
J Clin Gastroenterol. 2011 Apr;45(4):297-300. doi: 10.1097/MCG.0b013e3182098e07.
4
Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.粪便免疫化学检测用于在初级保健中对有下腹部症状的患者进行分流,以确定是否需要转诊疑似结直肠癌患者:一项系统评价和成本效益分析。
Health Technol Assess. 2017 May;21(33):1-234. doi: 10.3310/hta21330.
5
Are medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literature.行 FOBT 检查前是否需要限制用药?:基于文献系统评价的实用建议。
Can Fam Physician. 2012 Sep;58(9):939-48.
6
Screening strategies for colorectal cancer: a systematic review of the evidence.结直肠癌的筛查策略:证据的系统评价
Can J Gastroenterol. 2001 Oct;15(10):647-60. doi: 10.1155/2001/284746.
7
Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review.用于结直肠癌筛查的粪便潜血试验的诊断准确性:一项系统评价。
J Med Screen. 2007;14(3):132-7. doi: 10.1258/096914107782066220.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies.系统评价与荟萃分析:在结肠镜检查验证的诊断研究中,粪便潜血试验显示近端结肠癌的检出率较低。
Aliment Pharmacol Ther. 2016 Apr;43(7):755-64. doi: 10.1111/apt.13556. Epub 2016 Feb 9.
10
Screening for colorectal cancer using the faecal occult blood test, Hemoccult.使用便潜血试验(Hemoccult)筛查结直肠癌。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001216. doi: 10.1002/14651858.CD001216.pub2.

引用本文的文献

1
Biomarkers in inflammatory bowel disease: a practical guide.炎症性肠病中的生物标志物:实用指南
Therap Adv Gastroenterol. 2024 May 9;17:17562848241251600. doi: 10.1177/17562848241251600. eCollection 2024.
2
Adenoma location, size, and morphology are risk factors for FOBT false-negative results in inpatients with advanced colorectal adenoma.腺瘤位置、大小和形态是住院的伴有晚期结直肠腺瘤患者粪便隐血试验假阴性结果的危险因素。
Sci Rep. 2024 Jan 8;14(1):831. doi: 10.1038/s41598-024-51377-0.
3
Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
基于人群的结直肠癌筛查计划中,粪便免疫化学试验采用性别特异性截断值时的间隔期癌症。
J Med Screen. 2022 Sep;29(3):156-165. doi: 10.1177/09691413221085218. Epub 2022 Mar 8.
4
New considerations for colorectal cancer screening based on the demographic profile of colorectal cancer in a Greek population.基于希腊人群结直肠癌人口统计学特征的结直肠癌筛查新考量。
Mol Clin Oncol. 2022 Mar;16(3):57. doi: 10.3892/mco.2022.2490. Epub 2022 Jan 5.
5
Time Trends in the Diagnosis of Colorectal Cancer With Obstruction, Perforation, and Emergency Admission After the Introduction of Population-Based Organized Screening.人群为基础的结直肠癌筛查后引入后,伴梗阻、穿孔和急诊入院的结直肠癌诊断的时间趋势。
JAMA Netw Open. 2020 May 1;3(5):e205741. doi: 10.1001/jamanetworkopen.2020.5741.
6
Geographic variation and factors associated with colorectal cancer incidence in Manitoba.曼尼托巴省结直肠癌发病率的地理差异及相关因素
Can J Public Health. 2017 Sep;108(5-6):e558-e564. doi: 10.17269/CJPH.108.6091. Epub 2017 Sep 1.
7
Diagnostic Accuracy Of Fecal Occult Blood Tests For Detecting Proximal Versus Distal Colorectal Neoplasia: A Systematic Review And Meta-Analysis.粪便潜血试验检测近端与远端结直肠肿瘤的诊断准确性:一项系统评价与Meta分析
Clin Epidemiol. 2019 Oct 25;11:943-954. doi: 10.2147/CLEP.S213677. eCollection 2019.
8
Contribution of the OC Sensor immunoassay in comparison to the Hemoccult II guaiac-test in organized colorectal cancer screening.OC 传感器免疫测定与 Hemoccult II 愈创木脂检测在有组织的结直肠癌筛查中的比较。
Eur J Epidemiol. 2019 Feb;34(2):163-172. doi: 10.1007/s10654-018-0471-z. Epub 2018 Dec 8.
9
Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.灵活乙状结肠镜检查联合粪便免疫化学试验在结直肠癌筛查中的诊断性能:荟萃分析和建模。
Eur J Epidemiol. 2017 Jun;32(6):481-493. doi: 10.1007/s10654-017-0279-2. Epub 2017 Jun 30.
10
Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?粪便免疫化学检测作为炎症性肠病的生物标志物:它能与粪便钙卫蛋白相媲美吗?
Intest Res. 2016 Jan;14(1):5-14. doi: 10.5217/ir.2016.14.1.5. Epub 2016 Jan 25.